Nirogy Therapeutics Appoints Simon Pedder, Ph.D., as Chief Executive Officer | BioSpace
Willie -
9:24 am

Appointment strengthens leadership and expertise to drive lead oncology program into Phase 1 clinical development. Founding Chief Executive … Read source

Click to rate this post!
[Total: 0 Average: 0]